Try our Advanced Search for more refined results
Life Sciences - December, 2007
80 articles
- Plaintiffs Appeal Average Wholesale Price Ruling
- SEC Seeks Disgorgement From Safescript VIPs
- Ex-HealthSouth CFO Pleads Guilty In Bank Suit
- Paddock Labs Attorney Fee Bid Nixed
- Securities Cases To Watch In 2008
- Judge Deals Rare Class Denial In Sanofi FLSA Suit
- Northwestern Sells Drug Royalty Rights For $700M
- Product Liability Cases To Watch In 2008
- Institute Fires Off Suit Against Amgen Over Royalties
- GSK Hit With Another Avandia Wrongful Death Suit
- Abbott Faces $70M Suit Over Discontinued Stent
- Health Cases To Watch In 2008
- AstraZeneca Blasted For Seroquel Discovery Lapses
- Shareholders Fight Bid To Dismiss Part Of Apotex Suit
- Indirect Purchasers Bail Out Of Ditropan Suit
- Vitamin C Resellers Want Antitrust Suit Tossed
- EU Agency Probes Safety Of Pfizer's Champix
- The Shifting Scope Of Patentable Subject Matter
- Health Legislation To Watch In 2008
- FDA To Crack Down On Drug-Coated Stents: Report
- Two NuvaRing Cases Remanded To State Court
- HealthSouth, Drs. To Pay $14.9M In Kickbacks Case
- Lilly Wins Stay In Zyprexa Whistleblower Suit
- Merck Recalls 1.2M Vaccine Doses
- Claim Constructions Adopted In Catheter Patent Suit
- Barr Sues To Block Generic Seasonale
- Device Co. Closes Up Suture Suit Against Abbott
- Depomed Secures Summary Judgment Against Ivax
- Merck Puts Up $10M To Fix Creek Pollution
- Applied Medical Clears Seagate Test In Tyco Case
- Pfizer's Drug Distribution Deal Raises Concerns
- Wyeth Settles With J&J Unit Over Effexor Patent
- Director Bonuses And The Entire Fairness Test
- D.C. Council Moves To Rein In Drug Industry
- Jury Hands Bard $185M Verdict In Graft Patent Case
- AstraZeneca Fires Off 7 Suits Over Crestor ANDAs
- Congress Questions Results Of Cholesterol Study
- AstraZeneca Appeals $12.9M Judgment In AWP Case
- Merck To Develop New Drugs Despite Litigation Risks
- Judge Nails Medtronic With $226M Screw Judgment
- Novo Nordisk Settles Patent Dispute With Pfizer
- Pfizer Pushes To Toss More Cases From Bextra MDL
- Biovail Settles Securities Suit For $138M
- Free Drug Samples May Limit Costs In Antitrust Suits
- Pfizer Moves To Block Four Experts In Viagra MDL
- Pfizer Sues Cobalt Over Lipitor Patent
- RTI Opposes Split Of Becton Antitrust, Patent Claims
- Nexium, Prilosec Do Not Increase Heart Risks: FDA
- Class Certified In Medtronic Defibrillator Case
- Labor Dept. Finds CVS Violated Child Labor Laws
- Research Firm To Pay For Seroquel Discovery Request
- Deloitte & Touche Fined $1M For Drug Co. Audit
- ImClone Settles Patent Row With Yeda, Sanofi
- Pfizer FLSA Suit On Hold For Parallel MSJ Ruling
- Medtronic-Cordis Coronary Stent Suit Heads To Trial
- Judge Stands By Ruling For Wyeth In Prempro Case
- Plant Worker Pleads Guilty In Insider Trading Case
- Google Denied Stay For Antor Patent Re-Examination
- Aredia Plaintiffs Slam Novartis Bid For Ex-Parte Talks
- Abbott Labs Sues Zydus Over Depakote
- Novartis, Sun, Watson Strike Deal In Exelon MDL
- AstraZeneca Handed Partial Win In Seroquel Fight
- Nigeria Cuts Off Talks With Pfizer In Drug Trial Case
- Is A U.S. Patent More Difficult To Obtain After KSR?
- Judge Blasts Milberg, Skadden In Settlement Denial
- Cyberonics Settles Shareholder Suits Over Backdating
- Duane Morris Adds Four IP Attorneys
- Novartis' Anti-Seizure Drug New Target Of PL Suit
- GE Faces Suit Over Satellite Tracking Technology
- Judge Denies Fee Award To Pfizer In Celebrex Case
- Biovail Settles Cardizem Suit With Watson Unit
- Merck Reveals $670M Payment To Settle Probes
- Red Cross Wants J&J Expert's Testimony Tossed
- Growth Of Specialty Pharma Draws Generics Litigation
- Tug-Of-War Over Fosamax Class Continues
- Judge Finds Warner-Lambert Accupril Patent Enabled
- Court Won't Stay Generic Approval Of HDI Body Oil
- King Pharmaceuticals Loses Rehearing Bid
- Trial Date Set In Bextra, Celebrex Case
- Private Actions In U.K. Competition Law